We Talk About Our Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed pilot community-based research project will examine the feasibility, acceptability, and potential efficacy of the Storytelling intervention compared with usual care in hypertension control among rural residents in 4 communities in Vietnam. This is a major clinical and public health problem in this developing country.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Conquering Hypertension in Urban Vietnam

NCT06893198

Hypertension

ENROLLING_BY_INVITATION NA

Conquering Hypertension in Vietnam: Solutions at Grassroots Level

NCT03590691

Hypertension

COMPLETED NA

Evaluating the Effect of an Evidence-Based One Page With Supplemental Visual Aids on the Knowledge and Perceptions of Blood Pressure Management Among Adults With Hypertension

NCT04824560

Hypertension

COMPLETED NA

Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans

NCT00406614

Hypertension

COMPLETED NA

Using Stories to Address Disparities in Hypertension

NCT01276197

Hypertension

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Storytelling intervention

Two communes will be assigned to intervention group. Within each commune, 25 adults with HTN will be enrolled.

Patients will receive 2 DVDs with stories of patients who have successfully controlled their hypertension and "Learn More" section, which will be coordinated with specific patient stories and will fill in gaps not covered by the storytellers.

Group Type EXPERIMENTAL

Storytelling

Intervention Type BEHAVIORAL

The intervention will center on stories about living with hypertension, with patients speaking in their own words.

Usual care

Two communes will be assigned to usual care group. Within each commune, 25 adults with HTN will be enrolled.

Patients will receive 2 DVDs with only didactic material about common non-communicable diseases but without hypertension related stories.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Storytelling

The intervention will center on stories about living with hypertension, with patients speaking in their own words.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Consenting adult men and women must fulfill each of the following criteria:

1. be a resident of the selected commune;
2. be aged 50 years or older;
3. have a diagnosis of hypertension according to the 7th Joint National Commission of High Blood Pressure (JNC 7)
4. not be cognitively impaired (as assessed by study physicians)
5. not be a "story teller" used to develop the intervention;
6. not be a family member of another participant in the study

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No